DOES DEPRESCRIBING FALL-ASSOCIATED DRUGS REDUCE FALLS AND ITS COMPLICATIONS?: A SYSTEMATIC REVIEW

Abstract Falls are the leading cause of injury and injury-related hospitalizations for seniors in Canada with annual healthcare costs exceeding $2 billion. Despite limited evidence of effectiveness, the withdrawal (discontinuation or dose reduction) of “fall-risk increasing drugs” (FRIDs) is typically part of falls prevention strategies and hospital accreditation initiatives. The study objectives were to determine the preventative efficacy of …